bf/NASDAQ:APM_icon.jpeg

NASDAQ:APM

Aptorum Group Limited

  • Stock

USD

Last Close

1.36

06/11 21:00

Market Cap

19.48M

Beta: −0.02

Volume Today

15.84K

Avg: 12.53K

PE Ratio

−0.10

PFCF: −0.49

OverviewFinancialsAPI

    Description

    Aptorum Group Limited, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for the treatment of infectious diseases and cancer. The company operates in the Therapeutics and Non-Therapeutics segments. Its pipeline products include SACT- 1 for neuroblastoma and other cancer types; SACT-COV19 for the treatment of corona...Show More

    Excel Tearsheet

    Earnings

    Earnings per Share (Estimate*)

    -8-6-4-2242018-06-292019-12-302021-04-192022-09-302023-12-222024-12-19

    Revenue (Estimate*)

    5M10M15M20M2018-06-292019-12-302021-04-192022-09-302023-12-222024-12-19

    *Estimate based on analyst consensus